Richard Kirkpatrick, MD
Orthopaedic Surgery · Norman, OKNPI 1902813603
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,750 of the $8,599 with a category attached, or 78.5%. Zimmer Biomet accounts for 97.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $7,670 and has fallen 99.0% since, to $80 in 2025.
Across 31 payments — averaging $277.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$8K
- Smith+Nephew$148
- Gilead$38
- Innovation Technologies Inc$23
- Johnson & Johnson$13
- GSK$12
What the payments were for
- Consulting fees$6,75079%
- Travel & lodging$1,03912%
- Food & beverage$8109%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 24 | $8,365 |
| Smith+Nephew | 2 | $148 |
| Gilead | 2 | $38 |
| Innovation Technologies Inc | 1 | $23 |
| Johnson & Johnson | 1 | $13 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ROSA$7,476
- PPK$279
- ROSA-Knee$150
- SPATIAL FRAME$128
- Healicoil$128
- LENS 4K$128
- Bioinductive Implant with Arthroscopic Delivery System - Medium$128
How this compares
$8,599 in reported general payments places this provider in the 65th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 276 | $2,848 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 106 | $906 |
| Meloxicam | 63 | $409 |
| Celecoxib | 14 | $376 |
| Tramadol Hcl | 72 | $308 |
| Methylprednisolone | 26 | $225 |
| Mupirocin | 18 | $119 |
| Cyclobenzaprine Hcl | 29 | $93 |
| Hydromorphone Hcl | 13 | $82 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Norman
- Vytautas RingusNorman$272K
- Joshua WilsonNorman$40K
- Jeremiah MaupinNorman$20K
- James BondNorman$16K
- Yogesh MittalTulsa$6.6M
- Andrew ParkinsonOklahoma City$3.1M
- Bradley ReddickOklahoma City$573K
- Jason EmersonOklahoma City$189K
- Brian ChalkinTulsa$183K
- Ronald DumiganOklahoma City$169K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.